Month: September 2019

Exagen Announces Closing of Initial Public Offering

Cottonwood’s portfolio company Exagen (investment in 2011) announces closing of Initial Public Offering. Current enterprise value of Exagen Inc is $ 305 million (a growth of 2,300% in 8.5 years). Exagen Inc. (Nasdaq: XGN) is an organization dedicated to transforming...

Continue Reading

Scroll to top